Published in AIDS Weekly, February 5th, 2007
Study 1: Investigators publish new data in the report "Gene transfer in humans using a conditionally replicating lentiviral vector. We report findings from a clinical evaluation of lentiviral vectors in a phase I open-label nonrandomized clinical trial for HIV. This trial evaluated the safety of a conditionally replicating HIV-1-derived vector expressing an antisense gene against the HIV envelope," scientists writing in the journal Proceedings of the National Academy of Sciences of the United States of America report.
"Five subjects with chronic HIV infection who had...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.